Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascentage, Brii.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Everest, Immutep, Lixa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bioarctic, Clover Biopharmaceuticals, Feliqs, Gemvax & Kael, Henlius, Innovent, Jenscare, Recce, Remegen, Zai.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Forsee, J Ints Bio, Minghui, Zai Lab, Hope Medicines, Everest Medicines, Otsuka, Simcere.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Hutchmed.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aurigene, Innocare, Viatris.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Kazia, CSL, Henlius,

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amgen, Astrazeneca, Biocity, Biocon.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asieris, Biosyngen, Dizal, Eisai, Gan & Lee, Immvira, Immutep, Innovent, Insilico.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Apollomics, Astrazeneca, Biogen, Hightide, Innovent, QL Biopharmaceutical, Ractigen, Telix.